Therefore, those observations and our finding of SIM-mediated EZH2/H3K27Me3 suppression to activate γ-globin transcription could expand the treatment options for SCD by inhibiting EZH2 expression. The gene discussed is EZH2; the disease is Schnyder corneal dystrophy.